Search Browse Earnings

Invivyd, Inc.

Nasdaq:IVVD

Biological Products, (No Diagnostic Substances)·NEW HAVEN, CT

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Invivyd, Inc. — SlamSEC

Revenue

$25.4M

FY 2025

Adj. EBITDA

-$176.8M

-696.6% margin

FY 2025

Net Income

-$169.9M

-669.4% margin

FY 2025

EPS (Diluted)

-$1.43

FY 2025

Stock Price

$1.80

+3.7%

2026-03-06

52W Range

$0.46 – $3.07

P/E Ratio

-1.3x

Market Cap

$510.1M

Cash

$69.3M

FY 2025

Total Debt

—

Net Cash

$69.3M

FY 2025

Enterprise Value

$440.7M

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

-2.5x

Employees

—